Ticalicibart
Based on 1 Customer Validation
Ticalicibart is a humanized IgG4κ monoclonal antibody inhibitor targeting PCSK9. Ticalicibart has anti-hyperlipidaemic activity. Ticalicibart can be used for cardiovascular disease like hypercholesterolaemia research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.028%
- CAS. Nr.: 3033317-31-3
- Molecular Weight:145.631 kDa
-
Speicherung:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Isotype
Human IgG4 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
PCSK9
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG4-kappa
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized PCSK9 Protein, Human (HEK293, C-His, HY-P70545A) can bind Ticalicibart. The EC50 for this effect is 48.57 ng/mL.
Chemical Information
-
CAS. Nr. 3033317-31-3
-
Appearance Liquid
-
Molecular Weight 145.631 kDa
-
Color Colorless to off-white
-
SMILES
N/A
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (255 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)